Perrigo | PRGO - Equity Capital And Reserves


Perrigo reported $2.5B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AbbVie USD -6.66B 3.39B Mar/2026
Abbott USD 52.06B 69M Mar/2026
Bayer EUR 28.85B 2.9B Mar/2026
Bristol-Myers Squibb USD 20.07B 1.6B Mar/2026
Coherus Biosciences USD 61.01M 26.76M Dec/2025
Corcept Therapeutics USD 637.99M 9.82M Mar/2026
Dr.Reddys Laboratories INR 378.92B 3.16B Mar/2026
Eli Lilly USD 31.2B 4.66B Mar/2026
J&J USD 81.19B 358M Mar/2026
Merck USD 45.88B 6.73B Mar/2026
Nestle CHF 32.81B 3.98B Dec/2025
Pacira USD 653.89M 39.22M Mar/2026
Perrigo USD 2.5B 436.7M Mar/2026
Pfizer USD 90.1B 3.63B Mar/2026
Phibro Animal Health USD 361.83M 29.47M Mar/2026
Prestige Brands USD 1.89B 58.06M Mar/2026
Reckitt Benckiser GBP 6.7B 1.39B Dec/2024
Sanofi EUR 72.81B 1.1B Mar/2026
Supernus Pharmaceuticals USD 1.08B 15.09M Mar/2026
Teva Pharmaceutical Industries USD 8.23B 314M Mar/2026
Xeris Pharmaceuticals USD 13.01M 678K Mar/2026
Zoetis USD 3.23B 98M Mar/2026